Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata

Not Applicable

• Conditions: Alopecia Areata

• Registration Number: NCT01017510
• Lead Sponsor: Sheba Medical Center

Brief Summary

Conventional treatments include the use of steroids applied locally, or injection in to the legion, or oral therapy.

Treatment is determined by the severity of the disease.

Injection in to the legion can be done in two methods

1. Subcutaneous injection syringe Lower

2. Using syringe DERMOJET - a syringe without a needle. So far there are no publications in the medical literature of studies comparing efficacy, safety, convenience of use for doctor-patient, of both methods.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-11
• Study First Submitted: 2009-11-18
• Study First Submitted QC: 2009-11-19
• Study First Posted: 2009-11-20
• Status Verified: 2010-07
• Last Update Submitted: 2010-07-18
• Last Update Posted: 2010-07-20
• Primary Completion: 2010-11
• Study Completion: 2010-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Subjects over the age of 18
2. Men and women
3. The presence of at least two lesions (centers) in diameter of at least 1.5 cm on both sides of the scalp.
4. Healthy with no diseases that constitute the background against the total label use steroids

Exclusion Criteria

1. Pregnant women
2. Involvement of more then 50% of the scalp
3. Patients with immunodeficiency-related diseases
4. Patients receiving systemic steroids

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Evaluation of lesions will be based on Global assessment of improvement, score of 0-5	1 year

Secondary Outcome Measures

Name	Time	Method
Pain level will be evaluated based on a scale of 0-10	1 year

Trial Locations

Locations (1)

Sheba Medical Center; 🇮🇱 Rmat Gan, Israel